Optical monitoring of therapeutic drugs with a novel fluorescence-based POCT device

被引:16
作者
Berrettoni, C. [1 ,3 ]
Berneschi, S. [1 ]
Bernini, R. [2 ]
Giannetti, A. [1 ]
Grimaldi, I. A. [2 ]
Persichetti, G. [2 ]
Testa, G. [2 ]
Tombelli, S. [1 ]
Trono, C. [1 ]
Baldini, F. [1 ]
机构
[1] CNR, Inst Appl Phys Nello Carrara, Via Madonna del Piano 10, I-50019 Sesto Fiorentino, FI, Italy
[2] CNR, Inst Electromagnet Sensing Environm, I-80124 Naples, Italy
[3] Univ Siena, Dept Informat Engn & Math, I-53100 Siena, Italy
来源
28TH EUROPEAN CONFERENCE ON SOLID-STATE TRANSDUCERS (EUROSENSORS 2014) | 2014年 / 87卷
关键词
immunosuppressants; tacrolimus; optical biochip; fluorescence anisotropy; TACROLIMUS; BLOOD;
D O I
10.1016/j.proeng.2014.11.732
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
A novel optical biochip for immunosuppressants detection in transplanted patients is described. The optical working of the chip, based on total internal reflection fluorescence and consisting of two bonded polymeric parts, a Zeonex 330 slide and a Topas foil was demonstrated. In parallel, a heterogeneous competitive immunoassay for tacrolimus was implemented using a thirteen-microchannel optical chip interrogated by an in-house optical platform based on fluorescence anisotropy and the bioassay conditions were optimized: a limit of detection of 0.11 ng/mL, a limit of quantification of 0.57 ng/mL and a coefficient of variation of 25% were achieved. (C) 2014 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:392 / 395
页数:4
相关论文
共 6 条
[1]   A new procalcitonin optical immunosensor for POCT applications [J].
Baldini, F. ;
Bolzoni, L. ;
Giannetti, A. ;
Kess, M. ;
Kraemer, P. M. ;
Kremmer, E. ;
Porro, G. ;
Senesi, F. ;
Trono, C. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 393 (04) :1183-1190
[2]  
Berrettoni C., 2014, P SOC PHOTO-OPT INS, V8976
[3]   Equilibrium studies of a fluorescent tacrolimus binding to surfactant protein A [J].
Canadas, O ;
Sáenz, A ;
Orellana, G ;
Casals, C .
ANALYTICAL BIOCHEMISTRY, 2005, 340 (01) :57-65
[4]   Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral®) at day 7 post-renal transplantation and incidence of rejection in the first month [J].
Morris, RG ;
Russ, GR ;
Cervelli, MJ ;
Juneja, R ;
McDonald, SP ;
Mathew, TH .
THERAPEUTIC DRUG MONITORING, 2002, 24 (04) :479-486
[5]  
Streit F, 2002, CLIN CHEM, V48, P955
[6]  
Weltz A., 2014, Kidney Transplantation, P127